BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lam WKJ, Ji L, Tse OYO, Cheng SH, Jiang P, Lee PHP, Lin SV, Hui EP, Ma BBY, Chan ATC, Chan KCA, Chiu RWK, Lo YMD. Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles. Clin Chem 2020;66:598-605. [PMID: 32191318 DOI: 10.1093/clinchem/hvaa027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To KF, King AD, Ma BBY, Chan ATC. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol 2021. [PMID: 34194007 DOI: 10.1038/s41571-021-00524-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Trevisiol C, Gion M, Vaona A, Fabricio ASC, Roca E, Licitra L, Alfieri S, Bossi P. The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation. Oral Oncol 2021;114:105128. [PMID: 33444925 DOI: 10.1016/j.oraloncology.2020.105128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Miller JA, Sahoo MK, Yamamoto F, Huang C, Wang H, Zehnder JL, Le QT, Pinsky BA. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma. Mol Cancer 2022;21:154. [PMID: 35902864 DOI: 10.1186/s12943-022-01625-6] [Reference Citation Analysis]
4 Zhang W, Zhang J, Wang T, Wu Y, He Y, Xue W, Liao Y, Deng C, Li D, Wu Z, Yang D, Zheng X, Li X, Zhou T, Zhang P, Zhang S, Hu Y, Jia W. Genomic landscape of Epstein–Barr virus in familial nasopharyngeal carcinoma. Journal of General Virology 2022;103. [DOI: 10.1099/jgv.0.001728] [Reference Citation Analysis]
5 Vasudevan HN, Yom SS. Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus. Hematol Oncol Clin North Am 2021:S0889-8588(21)00063-0. [PMID: 34187713 DOI: 10.1016/j.hoc.2021.05.007] [Reference Citation Analysis]
6 Chang ET, Ye W, Ernberg I, Zeng YX, Adami HO. A novel causal model for nasopharyngeal carcinoma. Cancer Causes Control 2022;33:1013-8. [PMID: 35441278 DOI: 10.1007/s10552-022-01582-x] [Reference Citation Analysis]
7 Xue WQ, Wang TM, Huang JW, Zhang JB, He YQ, Wu ZY, Liao Y, Yuan LL, Mu J, Jia WH. A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China. Virus Evol 2021;7:veab010. [PMID: 34567789 DOI: 10.1093/ve/veab010] [Reference Citation Analysis]
8 Zhou X, Cao SM, Cai YL, Zhang X, Zhang S, Feng GF, Chen Y, Feng QS, Chen Y, Chang ET, Liu Z, Adami HO, Liu J, Ye W, Zhang Z, Zeng YX, Xu M. A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma. Nat Commun 2021;12:5189. [PMID: 34465768 DOI: 10.1038/s41467-021-25402-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]